A Win For First Wave BioPharma Inc.
Wed, Jan 03, 2024 at 07:46 PM
First Wave BioPharma Inc. (FWBI:NASDAQ) jumped higher at $5.46, representing a gain of 42.9%. On Wed, Jan 03, 2024, FWBI:NASDAQ touched a New 2-Week Intraday High of $6.15. The stock appeared on our News Catalysts scanner on Wed, Dec 27, 2023 at 03:11 PM in the 'PRIVATE PLACEMENT' category. From Thu, Dec 21, 2023, the stock recorded 42.86% Up Days and 25.00% Green Days
The stock spiked on Wed, Dec 27, 2023 at $14.51 with a volume of 26M+.
About First Wave BioPharma Inc. (FWBI:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- NexImmune Inc. (NEXI:NASDAQ), 153.06%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 94%
- Mmtec, Inc. (MTC:NASDAQ), 86.6%
- Sidus Space Inc. (SIDU:NASDAQ), 67%
- Hongli Group Inc. (HLP:NASDAQ), 55.3%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 54.2%
- F45 Training Holdings Inc. (FXLV:NYSE), 50%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 42.93%
- China Green Agriculture, Inc. (CGA:NYSE), 40%
- Airship AI Holdings Inc Com (AISP:NASDAQ), 38.75%